Fixed-dose rate gemcitabine plus docetaxel achieves objective response in 35% of patients with uterine leiomyosarcoma (uLMS). This study aimed to determine whether the addition of bevacizumab to ...

Objective: To assess the efficacy and safety profile of docetaxel, as a single agent, in the treatment of elderly patients with advanced breast cancer. Methods: Twenty-eight patients, with a median ...

PSA response and early PSA progression evaluated in patients randomized in a phase III trial comparing androgen deprivation therapy (ADT) plus docetaxel versus ADT alone in hormone-naive metastatic ...

Ceralasertib in combination with Imfinzi (durvalumab) did not meet the primary endpoint of overall survival (OS) in the phase ...

A total of 82 patients with HRPC were included. Of these, 71 patients were selected for second-line chemotherapy based on two or more consecutive increases in PSA not <14 days apart and/or objective ...

Patients with prostate cancer who receive docetaxel with standard-of-care treatment may have a reduced risk of death and an improved prognosis, according to a recent study. Patients with prostate ...

Although advanced urothelial carcinoma is a common and relatively chemosensitive neoplasm, it still remains a fatal disease. Over the last 10 years or so chemotherapy of advanced urothelial tumours ...

Docetaxel is a chemotherapy drug that is used to treat several different types of cancer. On the 19th of May 2004, the United States Food and Drugs Administration (US FDA) approved the use of ...

Adding docetaxel to androgen deprivation therapy (ADT) plus radiation therapy (RT) failed to improve survival in unfavorable-risk prostate cancer, though the combination may hold benefit for certain ...

Please provide your email address to receive an email when new articles are posted on . The regimen reduced risk for death by 32.5%. Data derived from Smith MR, et al. Abstract 13. Presented at: ASCO ...

Docetaxel is a chemotherapy drug that is used to treat several forms of cancer. On March 22nd 2006, the United States Food and Drug Administration (FDA) approved the use of docetaxel in combination ...

This study was conducted according to the guidelines of the Declaration of Helsinki and Good Clinical Practice, and all patients provided written, informed consent. The eligibility criteria included ...